Interpreting the results of noninferiority trials-a review.

Br J Cancer · 2022 · PMC9643416 · PMID 36104512

Europe PMC DOI

hedged sentence

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantP = 0.00004actually significant

Further, using all available follow-up (median 8.6 years), the absolute difference between treatments was substantially larger (60 vs 24 cases, 5.26% vs 2.07%, difference 3.19%) and this difference in proportions was highly significant ( P = 0.00004) [[ 13 ], Table 3].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.